Bridge Laboratories

Last updated: 13.02.2014

Address: 32 Kexue Yuan Road, Zhonggancun Life Science Park, Changping District, Beijing 102206,China

Tel: +86 10 8072 8800

Web: http://www.bridgelaboratories.com/

Company description

Bridge Laboratories is a preclinical contract research organization (CRO) that provides US-level regulatory-compliant drug development services globally. Bridge is US owned and headquartered in Gaithersburg, Maryland, with lab facilities in both the US and Beijing, China. Bridge is known for its extensive work in toxicology, including vaccines, developmental and reproductive toxicology (DART), and safety pharmacology. The company’s AAALAC-accredited facility in China was among the first labs to perform GLP studies for clients worldwide.

Products and services

Drug development services

Interview with Nicolas Milonas, Executive Vice President and CEO China,…

Could you provide us with an introduction to the company as well as your operations in Shanghai, New York or Singapore? I created Acropolis Associates ten years ago in New…

Interview with Maurizio Silvestri, President & CEO, Euticals Group

After a long experience at BMS, you are since 2002 at the head of Euticals- a well established group consisting of four entities (Euticals, Ambrosia, Prochisa and Pro.Bio.Sint), each of…

Page: 36 | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 article {"post_type":["article","interviews"],"posts_per_page":12,"tax_query":[{"taxonomy":"countries","field":"term_id","terms":126,"include_children":true}],"orderby":"date","order":"desc","max_num_pages":3,"paged":36,"post__not_in":[]}